Manuel J. Barbanoj
Centre d'Investigació de Medicaments
Institut de Recerca; Servei de Farmacologia Clínica
Hospital de la Santa Creu i Sant Pau
Departament de Farmacologia i Terapèutica
España
Name/email consistency: high
- Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers. Barbanoj, M.J., Clos, S., Romero, S., Morte, A., Giménez, S., Lorenzo, J.L., Luque, A., Dal-Ré, R. Neuropsychobiology (2005)
- Eberconazole cream: topical and general tolerability, sensitisation potential, and systemic availability. Barbanoj, M.J., Antonijoan, R., García-Gea, C., Puntes, M., Gich, I., Jané, F. Methods. Find. Exp. Clin. Pharmacol (2005)
- Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. Barbanoj, M.J., García-Gea, C., Morte, A., Izquierdo, I., Pérez, I., Jané, F. Neuropsychobiology (2004)
- A study comparing the inhibitory effects of single and repeated oral doses of ebastine and fexofenadine against histamine-induced skin reactivity. Barbanoj, M.J., Antonijoan, R.M., García-Gea, C., Morte, A., Gich, I., Gispert, J., Garcia, E., Esbrí, R., Luria, X. Int. Arch. Allergy Immunol. (2003)
